IPF and normal human lung fibroblasts (NHLF) were treated with IFN-γ, PFD or a combination of both drugs in the presence of either TGF-β1 or PDGF-BB. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.